BioReference Laboratories

BioReference is the largest full service specialty laboratory in the U.S. that gives providers & patients the power to make confident healthcare decisions.

[BioReference Laboratories @BioReference]

We are proud to support the #NYSCLA Annual Meeting, which will be held on Sept. 18-19, 2024.
The NYSCLA annual meeting is a must-attend event for NYSDOH-licensed labs. Learn more here: https://t.co/weLdufFDrb

[BioReference Laboratories @BioReference]

Are you attending #ASCO24? Meet our team at Booth 10086, and let's discuss how GenPath®, a specialty division of BioReference Health® can significantly enhance your #oncology diagnostic testing needs.

[BioReference Laboratories @BioReference]

Heading to #ASCO24? Meet us at booth #10086 to explore our latest innovations in #oncology diagnostic testing, including our new #HRD (Homologous Recombination Deficiency) test, and discover how we can streamline your oncology #diagnostic testing services.

[BioReference Laboratories @BioReference]

BioReference® honors laboratory professionals and pathologists during the 49th Annual Lab Week. We thank our dedicated lab professionals for making healthcare delivery possible. Read our blog https://t.co/Pb85xRuRQZ

[BioReference Laboratories @BioReference]

BioReference® has entered into a definitive agreement to sell certain assets of its clinical lab business with LabCorp but will maintain its national correction, urology/4Kscore®, oncology specialty services, and full operation in NY and NJ. https://t.co/JQzl7HoVhB

[BioReference Laboratories @BioReference]

If you are at @ASH_Hematology meeting and expo this weekend in #SanDiego, be sure to stop by booth 142 to talk with us about our OnkoSuite™ of products including the OnkoSight® Advanced and OnkoClone™. #ASH23

[BioReference Laboratories @BioReference]

Are you attending the @ASH_hematology #ASH23 Annual Meeting? Our team would love to connect! Meet us at booth 142 starting tomorrow in #SanDiego to learn how @GenPath Oncology's comprehensive test offerings can support the continuum of care for patients with blood disorders.

[ASH @ASH_hematology]

Let the excitement begin! Our journey into cutting-edge hematology starts tomorrow at the 65th ASH Annual Meeting. Explore the latest breakthroughs, connect with colleagues, and more.
View the agenda: https://t.co/KfwKA3qWwG.

Get ready for an unforgettable ASH adventure! #ASH23

[BioReference Laboratories @BioReference]

In #healthcare, data has become essential to driving better patient outcomes, and the is revolutionizing R&D. Explore the remarkable potential of #realworlddata and how its integration can lead to groundbreaking advancements in #cancertreatment. ➡️ https://t.co/1Z382cOZxD

[BioReference Laboratories @BioReference]

We are excited to see you at booth 142 during the @ASH_hematology annual meeting and expo in San Diego, December 9-12! @GenPath will be showcasing its comprehensive OnkoSuite™ for hematology and oncology diagnostics. #ASH23

[BioReference Laboratories @BioReference]

BioReference announces strategic collaboration with @PrognosAI to offer healthcare providers and researchers unique solutions to inform clinical studies and improve patient outcomes. Read more ➡️ https://t.co/eGcsm3gcNT #ReadWorldData #PrecisionMedicine

[BioReference Laboratories @BioReference]

#LungCancer represents more than one eighth of all new cancer cases in the US and is the leading cause of cancer deaths worldwide. As we wrap up #NationalLungCancerAwarenessMonth, get informed of the facts, signs, and symptoms. https://t.co/gnpbYkoFyg

[BioReference Laboratories @BioReference]

'Grow it Out' in honor of #men’shealth throughout #NoShaveNovember. Take time this month to talk to your healthcare provider about early detection screenings for #ProstateCancer, like the 4Kscore Test from OPKO, BioReference and GenPath. https://t.co/d1wYoV5pBv #Movember

[BioReference Laboratories @BioReference]

#DYK every 5 minutes, a woman will be diagnosed with a type of gynecological cancer. During Gynecologic Cancer Awareness Month help raise awareness of the various #gyncancers, their prevalence, symptoms, diagnosis and prevention. https://t.co/1rRgsfham1

[BioReference Laboratories @BioReference]

Medicare payment cuts threaten access to clinical laboratory services and undermine our nation’s laboratory infrastructure. Join @ACLAlabs today and tell Congress to protect patients and enact the Saving Access to Laboratory Services Act. https://t.co/ycHJk2EWjs

[BioReference Laboratories @BioReference]

Screening and diagnostic tests performed by clinical laboratories inform some of life’s most important health care decisions. Join @ACLAlabs to learn how you can help protect patient access to care by enacting #SALSA, and tell Congress to #StopLabCuts: https://t.co/Z3AkVVZzX0

[BioReference Laboratories @BioReference]

Please join us in congratulating Susan Aveta, VP Phlebotomy, for being recognized as an honoree of this year’s “Best 50 Women in Business” by @NJBIZ ➡️ https://t.co/eySs9T6J7z

[BioReference Laboratories @BioReference]

Today kicked-off #APF2023 National Meeting to promote management and leadership in pathology. If you are attending, join the sessions this week hosted by BioReference colleagues Tamera Paczos, MD; Jane Pine Wood, JD; and Robin Miller Zweifel, MT (ASCP). https://t.co/7k4Vp8UysX

[BioReference Laboratories @BioReference]

June is Men’s Health Month – a time that aims to encourage men to take charge of their overall health by implementing healthy living decisions. Take time to talk with your healthcare provider and loved ones about early detection and treatment. https://t.co/gxzzTaTB1R

[BioReference Laboratories @BioReference]

Routine tests play a critical role in healthcare, informing 70% of medical decisions (via @CDCgov ). Without action, about 800 tests will face payment cuts, threatening access to care. Take action with @ACLAlabs and tell Congress to pass #SALSA https://t.co/Z3AkVVZzX0